$MRK Recent News Updates, advisories and surprises 6:01

New Post Public Reply Private Reply Replies (0) Message Board

Feb 19, 2014 at 11:56 AM

$MRK Recent News

Updates, advisories and surprises 6:01 p.m. Feb. 5, 2014 - MarketWatch
U.S. stocks fall; data stoke fears of slowdown 4:31 p.m. Feb. 5, 2014 - Anora Mahmudova
Stocks dip, end off day's lows; Twitter falls after hours: stock market live blog recap 4:27 p.m. Feb. 5, 2014 - blogs.marketwatch.com
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
The big Merck news centers on cancer-drug collaborations with other giants 11:02 a.m. Feb. 5, 2014 - blogs.marketwatch.com
U.S. stock futures turn up before market open 9:21 a.m. Feb. 5, 2014 - Barbara Kollmeyer
Twitter, the Nikkei pattern and why this might be your last chance to buy 8:28 a.m. Feb. 5, 2014 - blogs.marketwatch.com
Merck 4Q profit falls on weaker sales 8:21 a.m. Feb. 5, 2014 - MarketWatch.com
Merck fourth-quarter profit, revenue fall 7:14 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck sees 2014 adj. EPS of $3.35 to $3.53 7:05 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 sales fall to $11.32 bln from $11.74 bln 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 profit falls to $781 mln from $908 mln 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Merck Q4 EPS $0.26; Adj. EPS $0.88 7:03 a.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
The market in a minute: Bull vs. bear margin thins 9:17 a.m. Feb. 3, 2014 - The Trading Deck
‘Par’ earnings not good enough after 2013 stock run-up 10:13 p.m. Jan. 31, 2014 - Wallace Witkowski
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Saumya Vaishampayan
Technical damage inflicted, S&P’s trend turns lower 11:49 a.m. Jan. 27, 2014 - Michael Ashbaugh
Merck hits a new high as analyst sees opening for new cancer drug 11:16 a.m. Jan. 27, 2014 - blogs.marketwatch.com

How to Invest for Income 10:50 a.m. Today - Barrons.com
Stock Market News for February 19, 2014 - Market News 10:06 a.m. Today - Zacks.com
Buy Recommendation Reiterated For Merck & Co Inc 9:00 a.m. Today - TheStreet.com
Prana: Expect Success In Massive Binary Event 1:19 p.m. Feb. 18, 2014 - Seeking Alpha
7 Monthly Pay Valentine Dogs Stalk 17% To 32% Upsides 1:06 p.m. Feb. 18, 2014 - Seeking Alpha
Wall Street Winners: Were Analyst 2014 Picks Worth Their Salt? 8:53 a.m. Feb. 18, 2014 - Seeking Alpha
Biotech Buyout Bolsters Novartis Cancer Portfolio 6:19 a.m. Feb. 17, 2014 - 247WallSt.com
Johnson & Johnson: Nothing to Fix Here 6:00 a.m. Feb. 17, 2014 - TheStreet.com
Ligand Pharmaceuticals: 5 Different Insiders Have Sold Shares This Month 1:46 a.m. Feb. 17, 2014 - Seeking Alpha
Merck: 7 Different Insiders Have Sold Shares This Month 3:04 a.m. Feb. 16, 2014 - Seeking Alpha
Merck's Decision To Sell Consumer Division Is Timely And Will Lead To A Higher Stock Price 6:38 p.m. Feb. 14, 2014 - Seeking Alpha
Big Pharma Will Find Good Hunting Among Early-Stage Biotechs: Dhesh Govender 11:56 a.m. Feb. 14, 2014 - Seeking Alpha
The 3 Best Vanguard Funds for an Uncertain Market 7:00 a.m. Feb. 14, 2014 - InvestorPlace.com
AbbVie Deserves More Respect 6:30 a.m. Feb. 14, 2014 - TheStreet.com
Pfizer Needs a Healthy Dose of Investor Love 6:00 a.m. Feb. 14, 2014 - TheStreet.com
8 Pharmaceutical Stocks to Buy Now 2:15 a.m. Feb. 14, 2014 - InvestorPlace.com
Celsion's Newest Cancer Treatment Adds To Upside 4:37 p.m. Feb. 13, 2014 - Seeking Alpha
Pfizer's Finally a Buy 1:13 p.m. Feb. 13, 2014 - Barrons.com
Marginal Earnings Beat at Hospira in Q4 (Revised) - Analyst Blog 11:20 a.m. Feb. 13, 2014 - Zacks.com
Feb. 13 Premarket Briefing: 10 Things You Should Know 8:09 a.m. Feb. 13, 2014 - TheStreet.com

Lupin Appoints Dr. Maurice Chagnaud as President-Europe & Head of Inhalation Strategy 8:05 a.m. Feb. 18, 2014 - PR Newswire - PRF
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors 8:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
John Daly, Worked With Merck, American Airlines, IBM and Is the White House Author of Advocacy 1:36 p.m. Feb. 17, 2014 - Marketwire
MSD Animal Health Receives Marketing Authorization from European Commission for BRAVECTO™ (fluralaner) 3:00 a.m. Feb. 17, 2014 - BusinessWire - BZX
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results and Highlights Recent Period Activities 4:00 p.m. Feb. 13, 2014 - BusinessWire - BZX
Sonrgy Announces Key Management Recruits 11:10 a.m. Feb. 13, 2014 - BusinessWire - BZX
Diabetes - KOL Insight and Consensus Outlook Modules 10:34 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
BIO-Europe Spring® Program in Turin Will Engage Executives in Provocative Topics Facing Drug Development Industry 9:00 a.m. Feb. 12, 2014 - BusinessWire - BZX
HTG Molecular Diagnostics Completes Initial Series E Preferred Stock Offering 7:02 a.m. Feb. 11, 2014 - Marketwire
Legal-Bay Lawsuit Settlement Funding Announce Settlements in Biomet Hip and NuvaRing Litigations 5:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes 8:30 a.m. Feb. 10, 2014 - BusinessWire - BZX
Absence of Blockbuster Drug Launches in 2014 Puts R&D Productivity at Risk 9:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Merck Announces Fourth-Quarter and Full-Year 2013 Financial Results 7:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Incyte Announces Clinical Trial Collaboration with Merck to Evaluate Combination of Two Novel Immunotherapies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Merck Enters Strategic Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475 6:40 a.m. Feb. 5, 2014 - BusinessWire - BZX
Amgen And Merck Announce Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma 6:15 a.m. Feb. 5, 2014 - PR Newswire - PRF
EffRx signs distribution agreements for Binosto® in Italy, Spain and Portugal 9:13 a.m. Feb. 4, 2014 - BusinessWire - BZX
Merck Announces Canadian Approval of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet) 8:30 a.m. Feb. 3, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investor Yazan Al Homsi Backs Arcanus Aerial for $500K

Yazan Al Homsi Backs Canadian Innovation Every once in a while, you see a move in the market that feels bigger than the numbers on the page. That's what this $500,000 from Yazan Al Homsi into Arcanus Aerial Systems does. Al Homsi, a UAE-based investor with a solid pedigree, decided to pump half a million bucks into Arcanus just as it's setting down roots in Canadian soil...

Mahomes Faces Pressure to Ditch AIRSHARE After Tragedy

Patrick Mahomes and the AIRSHARE Dilemma When the air turns turbulent, even the lucky stars often tremble. Kansas City Chiefs’ star quarterback, Patrick Mahomes, finds himself smack in the eye of such a storm. With a name as illustrious as his, the links to AIRSHARE, a private jet provider caught in the crosshairs of tragedy, create more than just a PR hiccup—they...

FOX News Revamps 2026 Election Coverage Playbook

Revamped Coverage: More Than Just Breaking News Yeah, everyone's clamoring about the midterms, but Fox News is doing more than just flipping on the camera and breaking the news every few minutes this year. They're rolling out the big guns: AI chatbots, flashy graphics, and special shows across multiple platforms. The point? To get viewers practically hooked and give 'em...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

John Wong's Decade as Estate Planning Specialist

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Aberdeen's Reverse Split: What Investors Need to Know

Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...

Finding Your Ideal Home Cleaning Schedule: Insights

Tackling the Mess: What's Your Cleaning Game Plan? We each have our tidiness tales, but when it comes down to keeping the household shipshape, the professional cleaning schedule you pick can make all the difference. A fresh-off-the-press breakdown from HelloNation and their expert David Merreot can guide you through the choices, cutting through the clutter of confusion....

Honeywell Aerospace Faces Class Action: Deadline Looms

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Bimbo Bakeries Teamsters Avert Strike in Chicago

Teamsters Flex Muscle in Bakery Dispute Sometimes, it's a matter of holding your ground until the last minute. That’s exactly the brand of guts the workers at Bimbo Bakeries in Chicago just displayed, securing a robust agreement mere hours before hitting the picket line. These 275 warehouse and route sales folks threw down the gauntlet with management and,...